Jan 5, 2016
Transgenic Chicken as ‘farmaceutical’ to treat lysosomal disease
Transgenic Chicken as ‘farmaceutical’ to treat lysosomal disease
Genetically engineered animals are in the spotlight yet again as the US government approved a transgenic drug producing chicken. In 2009, FDA has approved genetically modified goats that produce an anticoagulant called ATryn (antithrombin) in their milk. Last year, FDA authorized a drug for treating hereditary angioedema that is produced by transgenic rabbits. Last month, it has approved the…
View On WordPress